These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8738808)

  • 1. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    J Am Soc Nephrol; 1996 May; 7(5):728-36. PubMed ID: 8738808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Kidney Int; 1996 May; 49(5):1379-85. PubMed ID: 8731103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Am J Kidney Dis; 1996 Jul; 28(1):53-61. PubMed ID: 8712222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocalcemia, morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Hu L; O'Dea R; Murray DC; Barre PE
    Am J Nephrol; 1996; 16(5):386-93. PubMed ID: 8886175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and risk factors of ischemic heart disease in chronic uremia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray D; Barre PE
    Kidney Int; 1996 May; 49(5):1428-34. PubMed ID: 8731110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of dialysis therapy and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; O'Dea R; Murray DC; Barre PE
    J Am Soc Nephrol; 1998 Feb; 9(2):267-76. PubMed ID: 9527403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac function and hematocrit level.
    Harnett JD; Kent GM; Foley RN; Parfrey PS
    Am J Kidney Dis; 1995 Apr; 25(4 Suppl 1):S3-7. PubMed ID: 7702071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.
    Iliou MC; Fumeron C; Benoit MO; Tuppin P; Calonge VM; Moatti N; Buisson C; Jacquot C
    Am J Kidney Dis; 2003 Sep; 42(3):513-23. PubMed ID: 12955679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease.
    Foley RN; Parfrey PS; Kent GM; Harnett JD; Murray DC; Barre PE
    J Am Soc Nephrol; 2000 May; 11(5):912-916. PubMed ID: 10770969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malnutrition, cardiac disease, and mortality.
    Bergström J; Lindholm B
    Perit Dial Int; 1999; 19 Suppl 2():S309-14. PubMed ID: 10406538
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.
    Dubin RF; Guajardo I; Ayer A; Mills C; Donovan C; Beussink L; Scherzer R; Ganz P; Shah SJ
    Hypertension; 2016 Oct; 68(4):913-20. PubMed ID: 27550915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
    Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal aortic calcification score as a predictor of clinical outcome in peritoneal dialysis patients: a prospective cohort study.
    Ma D; Yan H; Yang X; Yu Z; Ni Z; Fang W
    BMC Nephrol; 2020 Apr; 21(1):151. PubMed ID: 32349690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Type Natriuretic Peptide Levels and Cardiac Dysfunction in Children on Peritoneal Dialysis.
    Park YS; Baek JS; Yu JJ; Kim YH; Ko JK; Lee JH
    Perit Dial Int; 2019; 39(3):210-219. PubMed ID: 30661005
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Martin CJ; Murray DC; Barre PE
    Kidney Int; 1995 Jan; 47(1):186-92. PubMed ID: 7731145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of aortic stiffness on survival in end-stage renal disease.
    Blacher J; Guerin AP; Pannier B; Marchais SJ; Safar ME; London GM
    Circulation; 1999 May; 99(18):2434-9. PubMed ID: 10318666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Prealbumin and Echocardiography Parameters Predict Mortality in Peritoneal Dialysis Patients.
    Ye M; Li J; Liu Y; He W; Lin H; Fan R; Li C; Li W; Zhang J; Huang H; Yao F
    Kidney Blood Press Res; 2020; 45(5):671-685. PubMed ID: 32998138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis.
    Hoppe K; Schwermer K; Olewicz-Gawlik A; Klysz P; Kawka A; Baum E; Sikorska D; Ścigacz K; Roszak M; Lindholm B; Pawlaczyk K; Oko A
    Adv Clin Exp Med; 2017; 26(2):251-258. PubMed ID: 28791842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.